SciBase Holding AB (publ) (FRA:5J3)

Market Cap	14.29M
Revenue (ttm)	3.31M
Net Income (ttm)	-8.18M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	20
Open	0.0084
Previous Close	0.0076
Day's Range	0.0084 - 0.0084
52-Week Range	0.0002 - 0.0422
Beta	n/a
RSI	51.17
Earnings Date	Feb 24, 2026

About SciBase Holding AB

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Ne...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1998
• Employees: 32
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5J3

Financial Performance

In 2024, SciBase Holding AB's revenue was 29.71 million, an increase of 27.79% compared to the previous year's 23.25 million. Losses were -61.13 million, 9.97% more than in 2023.

Financial numbers in SEK